VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
RAPP
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
RAPPRapport Therapeutics, Inc. Common Stock
$23.40$1.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksRAPPQuarterly Balance Sheet

Rapport Therapeutics, Inc. Common Stock (RAPP) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Rapport Therapeutics, Inc. Common Stock (RAPP) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

RAPP Balance Sheet

Quarterly statement

RAPP Balance Sheet

Rapport Therapeutics, Inc. Common Stock (RAPP) balance sheet — 4-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Total Current Assets407.38M446.86M484.69M498.56M520.66M270.24M290.97M309.8M325.94M340.67M198.73M150.87M
Cash & Short-Term Investments395.03M436.08M476.78M490.54M513.03M260.45M285.38M305.28M320.66M336.14M193.24M147.48M
Cash Only74.75M63.61M78.06M52.65M251.36M55.07M57.6M56.8M39.31M110.16M74.27M70.17M
Short-Term Investments320.27M372.46M398.73M437.89M261.67M205.38M227.78M248.47M281.35M225.97M118.98M77.31M
Accounts Receivable171K293K58K000000000
Days Sales Outstanding--0.26---------
Inventory000000000000
Days Inventory Outstanding------------
Other Current Assets105K105K7.86M8.02M7.63M9.79M5.59M4.52M5.28M4.53M5.48M3.39M
Total Non-Current Assets11.18M12.13M12.9M13.87M14.66M15.25M11.09M5.13M5.21M5.43M7.56M4.55M
Property, Plant & Equipment10.08M11.07M11.85M12.88M13.6M14.22M10.87M4.97M5.02M5.24M5.49M4M
Fixed Asset Turnover--1.62x---------
Goodwill000000000000
Intangible Assets000000000000
Long-Term Investments000000000000
Other Non-Current Assets1.09M1.06M1.06M985K1.07M1.03M211K160K189K189K2.07M551K
Total Assets418.56M458.98M497.6M512.43M535.32M285.5M302.05M314.93M331.14M346.1M206.29M155.42M
Asset Turnover--0.04x---------
Asset Growth %-21.81%60.77%64.74%62.71%61.66%-17.51%46.42%102.63%----
Total Current Liabilities20.3M28.42M17.9M19.05M14.32M11.88M9.38M8.77M7.1M8.1M9.88M8.8M
Accounts Payable1.72M2.8M6.56M4.19M3.23M3.18M2.14M1.95M1.32M1.88M1.45M2.5M
Days Payables Outstanding-----------12.02K
Short-Term Debt000000000000
Deferred Revenue (Current)000000000000
Other Current Liabilities04.25M3.08M7.12M5.04M3.14M2.1M3.71M3.23M1.71M1.04M2.41M
Current Ratio20.07x15.72x27.08x26.17x36.37x22.75x31.01x35.34x45.91x42.08x20.10x17.14x
Quick Ratio20.07x15.72x27.08x26.17x36.37x22.75x31.01x35.34x45.91x42.08x20.10x17.14x
Cash Conversion Cycle------------
Total Non-Current Liabilities7.07M7.63M8.19M8.73M9.39M10.1M6.83M739K931K1.12M236.04M172.25M
Long-Term Debt008.19M8.73M9.39M0000000
Capital Lease Obligations7.07M7.63M00010.1M6.83M739K931K1.12M1.3M1.48M
Deferred Tax Liabilities000000000000
Other Non-Current Liabilities0000000000234.74M170.78M
Total Liabilities27.37M36.06M26.09M27.78M23.71M21.98M16.22M9.51M8.03M9.21M245.92M181.06M
Total Debt9.39M10.11M10.8M11.48M11.87M11.86M7.84M1.48M1.65M1.82M1.98M2.15M
Net Debt-65.36M-53.51M-67.25M-41.16M-239.49M-43.2M-49.76M-55.33M-37.66M-108.34M-72.28M-68.02M
Debt / Equity0.02x0.02x0.02x0.02x0.02x0.05x0.03x0.00x0.01x0.01x--
Debt / EBITDA------------
Net Debt / EBITDA------------
Interest Coverage------------
Total Equity391.19M422.93M471.51M484.65M511.62M263.51M285.84M305.43M323.11M336.89M-39.63M-25.63M
Equity Growth %-23.54%60.5%64.96%58.68%58.34%-21.78%821.21%1291.49%----
Book Value per Share8.198.919.9810.3213.497.438.118.7116.8516.75-2.04-1.42
Total Shareholders' Equity391.19M422.93M471.51M484.65M511.62M263.51M285.84M305.43M323.11M336.89M-39.63M-25.63M
Common Stock48K48K48K48K48K37K37K37K36K36K4K4K
Retained Earnings-351.94M-311.7M-255.09M-235.23M-201.47M-174.54M-147.81M-123.75M-103.77M-86.23M-68.11M-45.44M
Treasury Stock000000000000
Accumulated OCI-2.12M-1.27M-505K546K145K-76K-95K-522K400K-183K-160K4K
Minority Interest000000000000